Abstract P4-12-28: Discovery and Validation of Novel Small G Protein Inhibitor OSURALi for Targeting Triple Negative Breast Cancer
Dillon S. Richardson, Steven T. Sizemore(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 0
Related Papers
The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer
|Breast Cancer Research|2021|17